Antagonistic regulation of transmembrane 4 L6 family member 5 attenuates fibrotic phenotypes in CCl 4-treated mice

FEBS Journal

Volumn 279, Issue 4, 2012, Pages 625-635

  Kang, Minkyung ^a   Jeong, Soo Jin ^b   Park, Sook Young ^a   Lee, Hyo Jeong ^b   Kim, Hyun Jeong ^a   Park, Ki Hun ^c   Ye, Sang Kyu ^a   Kim, Sung Hoon ^b   Lee, Jung Weon ^a  

^a Seoul National University   (South Korea)

^b Kyung Hee University   (South Korea)

^c Gyeongsang National University   (South Korea)

Author keywords

anti TM4SF5; CCl 4 mediated liver injury model; cytokine; liver fibrosis; tetraspanin

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MEMBRANE PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSMEMBRANE 4 L6 FAMILY MEMBER 5; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER FIBROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ACTINS; ANIMALS; BLOTTING, WESTERN; CARBON TETRACHLORIDE; CELL LINE; CHALCONE; COLLAGEN TYPE I; EPIDERMAL GROWTH FACTOR; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MUSCLE, SMOOTH; SIGNAL TRANSDUCTION; SULFONAMIDES; TRANSFORMING GROWTH FACTOR BETA1;

MUS;

EID: 84862816136     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2011.08452.x     Document Type: Article

References (20)

1. Kalluri R, &, Neilson EG, (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112, 1776-1784. (Pubitemid 38063698)
2. Gressner AM, &, Weiskirchen R, (2006) Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets. J Cell Mol Med 10, 76-99. (Pubitemid 44874293)
3. Jarcuska P, Janicko M, Veseliny E, &, Skladany L, (2010) Circulating markers of liver fibrosis progression. Clin Chim Acta 411, 1009-1017.
4. Severi T, van Malenstein H, Verslype C, &, van Pelt JF, (2010) Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets. Acta Pharmacol Sin 31, 1409-1420.
5. Choi SS, &, Diehl AM, (2009) Epithelial-to-mesenchymal transitions in the liver. Hepatology 50, 2007-2013.
6. Caja L, Ortiz C, Bertran E, Murillo MM, Miro-Obradors MJ, Palacios E, &, Fabregat I, (2007) Differential intracellular signalling induced by TGF-β in rat adult hepatocytes and hepatoma cells: implications in liver carcinogenesis. Cell Signal 19, 683-694. (Pubitemid 46275361)
7. Bataller R, &, Brenner DA, (2005) Liver fibrosis. J Clin Invest 115, 209-218. (Pubitemid 40385459)
8. Lee SA, Lee SY, Cho IH, Oh MA, Kang ES, Kim YB, Seo WD, Choi S, Nam JO, Tamamori-Adachi M, et al. (2008) Tetraspanin TM4SF5 mediates loss of contact inhibition through epithelial-mesenchymal transition in human hepatocarcinoma. J Clin Invest 118, 1354-1366. (Pubitemid 351500429)
9. Wright MD, Ni J, &, Rudy GB, (2000) The L6 membrane proteins-a new four-transmembrane superfamily. Protein Sci 9, 1594-1600. (Pubitemid 30659198)
10. Muschel RJ, &, Gal A, (2008) Tetraspanin in oncogenic epithelial-mesenchymal transition. J Clin Invest 118, 1347-1350. (Pubitemid 351500427)
11. Kim H, Kang M, Lee SA, Kwak TK, Jung O, Lee HJ, Kim SH, &, Lee JW, (2010) TM4SF5 accelerates G1/S phase progression via cytosolic p27(Kip1) expression and RhoA activity. Biochim Biophys Acta 1803, 975-982.
12. Lee SA, Kim TY, Kwak TK, Kim H, Kim S, Lee HJ, Kim SH, Park KH, Kim HJ, Cho M, et al. (2010) Transmembrane 4 L six family member 5 (TM4SF5) enhances migration and invasion of hepatocytes for effective metastasis. J Cell Biochem 111, 59-66.
13. Sangiovanni A, Del Ninno E, Fasani P, De Fazio C, Ronchi G, Romeo R, Morabito A, De Franchis R, &, Colombo M, (2004) Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 126, 1005-1014. (Pubitemid 38451172)
14. Lee SA, Ryu HW, Kim YM, Choi S, Lee MJ, Kwak TK, Kim HJ, Cho M, Park KH, &, Lee JW, (2009) Blockade of four-transmembrane L6 family member 5 (TM4SF5)-mediated tumorigenicity in hepatocytes by a synthetic chalcone derivative. Hepatology 49, 1316-1325.
15. Seo WD, Kim JH, Kang JE, Ryu HW, Curtis-Long MJ, Lee HS, Yang MS, &, Park KH, (2005) Sulfonamide chalcone as a new class of alpha-glucosidase inhibitors. Bioorg Med Chem Lett 15, 5514-5516. (Pubitemid 41562981)
16. Lee SA, Park KH, &, Lee JW, (2011) Modulation of signaling between TM4SF5 and integrins in tumor microenvironment. Front Biosci 16, 1752-1758.
17. Zhong W, Shen WF, Ning BF, Hu PF, Lin Y, Yue HY, Yin C, Hou JL, Chen YX, Zhang JP, et al. (2009) Inhibition of extracellular signal-regulated kinase 1 by adenovirus mediated small interfering RNA attenuates hepatic fibrosis in rats. Hepatology 50, 1524-1536.
18. Meindl-Beinker NM, &, Dooley S, (2008) Transforming growth factor-β and hepatocyte transdifferentiation in liver fibrogenesis. J Gastroenterol Hepatol 23 (Suppl 1), S122-S127. (Pubitemid 351389043)
19. Wynn TA, (2008) Cellular and molecular mechanisms of fibrosis. J Pathol 214, 199-210. (Pubitemid 351160157)
20. Beaussier M, Wendum D, Schiffer E, Dumont S, Rey C, Lienhart A, &, Housset C, (2007) Prominent contribution of portal mesenchymal cells to liver fibrosis in ischemic and obstructive cholestatic injuries. Lab Invest 87, 292-303. (Pubitemid 46353940)